ÐÇ¿Õ´«Ã½

Success Stories

While there have been countless success stories from ÐÇ¿Õ´«Ã½ startups, a handful of our companies have enjoyed particularly notable exits.

Lucid Diagnostics

in 2021. The company’s  esophageal cancer prevention tests were developed jointly by medical school faculty at ÐÇ¿Õ´«Ã½ and University Hospitals. .

Rodeo Therapeutics

Publicly traded biopharmaceutical company in 2020, with the potential for up to $666 million if developmental milestones are reached. .

PolymerPlus

In 2020, , a Cleveland-based polymeric development company founded at ÐÇ¿Õ´«Ã½, for $25 million.

NervGen Pharma 

Vancouver-based NervGen Pharma Corp., a company founded to develop regenerative-medicine technology licensed from ÐÇ¿Õ´«Ã½, in 2019. .

View More of Our Startup Portfolio 

By the Numbers 

$50 million+ 

Amount of follow-on investment ÐÇ¿Õ´«Ã½ startups have attracted

100+

Startup companies from ÐÇ¿Õ´«Ã½ since 2001

$600 million+

Amount raised by ÐÇ¿Õ´«Ã½â€™s portfolio of spinoffs since 2017

Get in Touch

Looking to launch your own startup at ÐÇ¿Õ´«Ã½? We’re here to help.